In addition, increasing studies attempted to show the transcript ratio of FLT3 + KIT/BCL2, FLT3/BCL2, and BAX/BCL2 (or combined with WT1 or MDR1) may affect prognosis in AML [25–28]. The gene discussed is FLT3; the disease is acute myeloid leukemia.